The present invention provides a method for treating an ocular disease in a subject in need thereof comprising administering an effective amount of a compound of Formula (A) to the subject. Also provided is a pharmaceutical composition for treating an ocular disease which comprises compound of Formula (A) and a pharmaceutically acceptable carrier.